Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045459
Filing Date
2024-11-06
Accepted
2024-11-06 07:42:54
Documents
91
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20240930.htm   iXBRL 10-Q 1470493
2 EX-10.1 lnth10q-093024ex101.htm EX-10.1 10802
3 EX-31.1 lnth10q-093024ex311.htm EX-31.1 11669
4 EX-31.2 lnth10q-093024ex312.htm EX-31.2 11572
5 EX-32.1 lnth10q-093024ex321.htm EX-32.1 9752
  Complete submission text file 0001628280-24-045459.txt   8127331

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20240930.xsd EX-101.SCH 55392
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20240930_cal.xml EX-101.CAL 86305
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20240930_def.xml EX-101.DEF 245207
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20240930_lab.xml EX-101.LAB 702320
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20240930_pre.xml EX-101.PRE 491236
94 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20240930_htm.xml XML 1167637
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 241429265
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)